Unknown OBSERVATIONAL NCT05053815

Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting

Retrospective Study Assessing the Value of Pharmacogenomic Testing in a Program of All-inclusive Care for the Elderly (PACE) Setting

Sponsor: Tabula Rasa HealthCare

Conditions Pharmacogenomics Polypharmacy

Interventions Pharmacogenomic Testing

Updated 6 times since 2021 Last updated: Sep 1, 2022 Started: Nov 2, 2021 Primary completion: Nov 1, 2023 Completion: Mar 1, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Pharmacogenomics and Polypharmacy and is currently ongoing. Tabula Rasa HealthCare leads this study, which shows 6 recorded versions since 2021 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Oct 2024 — Present [monthly]

Unknown

Status: Enrolling By Invitation → Unknown
Sep 2024 — Oct 2024 [monthly]

Enrolling By Invitation
Jul 2024 — Sep 2024 [monthly]

Enrolling By Invitation
Sep 2022 — Jul 2024 [monthly]

Enrolling By Invitation
Jan 2022 — Sep 2022 [monthly]

Enrolling By Invitation

Status: Not Yet Recruiting → Enrolling By Invitation

▶ Show 1 earlier version

Oct 2021 — Jan 2022 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Tabula Rasa HealthCare

Data source: Tabula Rasa HealthCare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Orlando, United States